Feminising hormone therapy reduces testicular ACE‐2 receptor expression: Implications for treatment or prevention of COVID‐19 infection in men
John M. Masterson(Cedars-Sinai Medical Center), Maurice M. Garcia(Cedars-Sinai Medical Center), Wohaib Hasan(Cedars-Sinai Medical Center), Xiaopen Yuan(Cedars-Sinai Medical Center), Warren G. Tourtellotte(Cedars-Sinai Medical Center), Daniel Luthringer(Cedars-Sinai Medical Center), Yi Zhang(Tianjin Medical University General Hospital), Harneet Jawanda(Cedars-Sinai Medical Center), Chau M. Bui(Cedars-Sinai Medical Center), Carissa A. Huynh(Cedars-Sinai Medical Center)
Cited by 8
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
|Science|1995|1.5k